Phage Endolysins as Promising and Effective Candidates for Use Against Uropathogenic Escherichia coli
Viruses · 2025
DOI: 10.3390/v17040560 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Viruses, 2025. Verfasst von Wojciech Wesołowski und 8 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Biology and Biotechnology of Bacteriophages, Department of Molecular Biology, Faculty of Biology, University of Gdańsk, Wita Stwosza 59…. Hauptthemen laut MEDLINE: Uropathogenic Escherichia coli, Endopeptidases, Bacteriophages, Anti-Bacterial Agents. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Centre, UG Young Researcher grant program, UGrants - start.
Abstract (Originalsprache)
The presented in silico and phylogenetic analysis of putative endolysins potentially produced by phages infecting uropathogenic Escherichia coli (UPEC) demonstrates their remarkable diversity. These proteins exhibit significant variations in sequence length, molecular weight, isoelectric point, and stability, as well as diverse functional domains determining their enzymatic activity, including lysin, lysozyme, hydrolase, amidase, and peptidase functions. Due to their predicted lytic properties, endolysins hold great promise in combating UPEC bacteria, including those within biofilms, which are often highly resistant to conventional treatments. Despite their potential, several challenges hinder the full utilization of endolysins. These include the relatively small number of identified proteins, challenges in the annotation process, and the scarcity of studies evaluating their efficacy in vitro and in vivo against Gram-negative bacteria. In this work, we emphasize these challenges while also underlining the potential of endolysins as an effective tool against UPEC infections. Their effectiveness could be significantly enhanced when combined with agents that disrupt the outer membrane of these bacteria, making them a promising alternative or complement to existing antimicrobial strategies. Further research is necessary to fully explore their therapeutic potential.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Biology and Biotechnology of Bacteriophages, Department of Molecular Biology, Faculty of Biology, University of Gdańsk, Wita Stwosza 59, 80-308 Gdansk, Poland.
- BNF-New Bio Force Ltd., Kartuska 420a, 80-125 Gdańsk, Poland.
- Laboratory of Environmental Chemoinformatics, Faculty of Chemistry, University of Gdansk (UG), Wita Stwosza 63, 80-309 Gdansk, Poland.
ORCID-Profile: Wojciech Wesołowski, Aleksandra Łukasiak, Emilia Węglińska, Grzegorz Węgrzyn, Bożena Nejman-Faleńczyk
Förderung
- National Science Centre
- UG Young Researcher grant program
- UGrants - start
- UG Young Resercher
- UGrants-start
Zitieren
APA
Wesołowski, W., Łukasiak, A., Bloch, S., Kuligowska, K., Neumann, J., Lewandowska, N., Węglińska, E., Węgrzyn, G., & Nejman-Faleńczyk, B. (2025). Phage Endolysins as Promising and Effective Candidates for Use Against Uropathogenic Escherichia coli. Viruses. https://doi.org/10.3390/v17040560
Vancouver
Wesołowski W, Łukasiak A, Bloch S, Kuligowska K, Neumann J, Lewandowska N, et al. Phage Endolysins as Promising and Effective Candidates for Use Against Uropathogenic Escherichia coli. Viruses. 2025. doi:10.3390/v17040560
BibTeX
@article{Wesoowski2025,
author = {Wesołowski, Wojciech and Łukasiak, Aleksandra and Bloch, Sylwia and Kuligowska, Kaja and Neumann, Julia and Lewandowska, Natalia and Węglińska, Emilia and Węgrzyn, Grzegorz and Nejman-Faleńczyk, Bożena},
title = {Phage Endolysins as Promising and Effective Candidates for Use Against Uropathogenic Escherichia coli},
journal = {Viruses},
year = {2025},
doi = {10.3390/v17040560}
}
EUVIMED